文献速递肺结节与肺癌

乡村性、分期分层治疗模式使用与非小细胞肺癌生存

Rurality, Stage-Stratified Use of Treatment Modalities, and Survival of Non-small Cell Lung Cancer.
PubMed 文献 · Chest · 2020-05-06

研究分析一个社区医疗系统五个机构2011-2017年6259例NSCLC患者,47%居住在农村。调整保险、年龄和临床分期后,在城市机构就诊的城市和农村居民接受分期首选治疗的可能性更高,死亡风险更低;机构层面差异大于患者层面。

要点

  • 农村居民在城市机构就诊的结局与城市居民在城市机构就诊相似。
  • 机构层面差异大于患者层面差异,干预应优先针对机构层面。
  • 调整后城市机构就诊者接受分期首选治疗的OR为1.68和1.33。

核心结论

  • 乡村相关的治疗和生存差异存在于患者和机构层面,但机构层面差异更大。
  • 在农村机构就诊的农村居民结局最差,在城市机构就诊的农村居民结局与城市居民相似。

研究设计与样本

  • 回顾性队列研究,分析一个社区医疗系统五个机构2011至2017年的6259例非小细胞肺癌患者。
  • 机构层面和患者层面乡村性基于城乡通勤区代码判定,47%患者居住在农村,五个机构中两个位于农村并诊治20%患者。

主要发现

  • 调整保险、年龄和临床分期后,在城市机构就诊的城市和农村居民接受分期首选治疗的OR分别为1.68(95%CI 1.44-1.96)和1.33(95%CI 1.11-1.61),参照组为在农村机构就诊的农村居民。
  • 在城市机构就诊的城市和农村居民死亡风险低于在农村机构就诊的农村居民,HR分别为0.69(95%CI 0.64-0.75)和0.61(95%CI 0.55-0.67)。
  • 在接受分期首选治疗的患者中,城市机构就诊的死亡风险仍较低,HR为0.7(95%CI 0.63-0.79)。
  • 进一步按分期分层,晚期患者在城市机构就诊的死亡风险仍较低,HR为0.8(95%CI 0.71-0.91)。

临床怎么用

  • 为缩小乡村相关NSCLC生存差异,干预应优先针对机构层面,包括扩大高质量指南 concordant 治疗的可及性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To eliminate them, non-small cell lung cancer (NSCLC) care and outcome disparities need to be better understood. RESEARCH QUESTION: How does rurality interact with NSCLC care and outcome disparities? STUDY DESIGN AND METHODS: We examined guideline-concordant use of active treatment for NSCLC across five institutions in one community-based health care system spanning 44% of the Delta Regional Authority catchment area from 2011 to 2017. Institution- and patient-level rurality were based on Rural-Urban Commuting Area codes. Chi-squared, F-tests, and logistic regressions were used to analyze differences across institutions and rurality; survival was examined using log-rank tests and Cox regression. RESULTS: Of 6,259 patients, 47% resided in rural areas; two of five institutions were rurally located and provided care for 20% of patients. Compared with rural residents at rural institutions, urban and rural residents attending urban institutions were more likely to receive stage-preferred treatment: OR 1.68 (95%CI, 1.44-1.96), and 1.33 (1.11-1.61), respectively, after adjusting for insurance, age, and clinical stage. Urban and rural residents attending urban institutions had a lower hazard of death compared with rural residents attending rural institutions: hazard ratio (HR) 0.69 (0.64-0.75) and 0.61 (0.55-0.67), respectively. Among recipients of stage-preferred treatment, care at urban institutions remained less hazardous: HR 0.7 (0.63-0.79). When further stratified by stage, care for late-stage patients at urban institutions remained less hazardous: HR 0.8 (0.71-0.91). INTERPRETATION: Rurality-associated treatment and survival disparities were present at the patient and institution levels, but the institution-level disparity was greater. Rural residents receiving care at urban institutions had similar outcomes to urban residents receiving care at urban hospitals. To overcome rurality-associated NSCLC survival disparity, interventions should preferentially target the institution level, including expanding access to higher-quality guideline-concordant care.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Ray MA, Faris NR, Derrick A, et al. Rurality, Stage-Stratified Use of Treatment Modalities, and Survival of Non-small Cell Lung Cancer. Chest. 2020. PMID: 32387525. doi:10.1016/j.chest.2020.04.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。